Bryan Garnier - Pharmaceuticals, Biotech | New Biden plan to lower drug prices is not…new nor voted

Report

Bryan Garnier

Jean-Jacques Le Fur

Pharmaceuticals, Biotech | New Biden plan to lower drug prices is not…new nor voted

10/09/2021 3 EN

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Jean-Jacques Le Fur

Other Reports from Bryan Garnier

Damien Choplain ... (+2)

Damien Choplain
Oscar Haffen Lamm

Initiation of coverage: The 'Clever' way to tackle MDS

Faron Pharmaceuticals is a Finnish biotech developing bexmarilimab (BEX), an immunotherapy in late stage development for the treatment of a rare type of hematologic cancer, high-risk myelodysplastic syndrome (HR-MDS). Encouraging phase 2 data supports a phase 3 trial starting H1 2026, targeting bot

14h / 55m 14h / 55m 1 EN

Clément Genelot

Clément Genelot

Jeronimo Martins: Q2 to reinforce recovery momentum and rerating case

Ahead of H1 2025 earnings on 1st August, we have lifted our Q2 2025E sales forecasts to 8.1% o/w 4.5% LfL excluding calendar and more globally our FY25-27 EPS estimates by 2% to reflect a stronger LfL recovery in Poland (fuelled by food inflation and an easing in the price war) and better margin de

22h / 37m 22h / 37m 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Waga Energy: CAD25m debt refinancing

Yesterday, Waga Energy announced it has secured a CAD25m (~EUR16m) non-recourse loan from Equitable Bank and Empire Life. The 19-year non-recourse financing is dedicated to the refinancing of three operating RNG production units, namely Saint-Étienne-des-Grés, Chicoutimi, and Cowansville in Quebec.

July 4, 2025 July 4, 2025 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

Pharmaceuticals, Biotech | New Biden plan to lower drug prices is not…new nor voted

Initiation of coverage: The 'Clever' way to tackle MDS

Jeronimo Martins: Q2 to reinforce recovery momentum and rerating case

Waga Energy: CAD25m debt refinancing

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe